Trial intelligence / Profile preview

Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis

NCT00210990Phase 3Completed

Sponsor
Johnson & Johnson
Start
Mar 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of doripenem in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Johnson & Johnson. Started Mar 2004; status: completed.

02

Drugs

doripenem
03

Conditions

complicated urinary tract infection (cUTI)pyelonephritis

Beyond the preview

Go deeper on NCT00210990.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00210990.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call